Changes

making style consistent, removing duplicates
Line 7: Line 7:  
|'''Significance (Recurrent, Diagnostic, Prognostic, Targeted treatment)'''
 
|'''Significance (Recurrent, Diagnostic, Prognostic, Targeted treatment)'''
 
|'''Strength of Evidence (Level 1, 2, 3, see legend below table for criteria)'''
 
|'''Strength of Evidence (Level 1, 2, 3, see legend below table for criteria)'''
|'''References'''  
+
|'''References'''
 
|-
 
|-
 
| rowspan="9" |1
 
| rowspan="9" |1
Line 33: Line 33:  
|1p13.2
 
|1p13.2
 
|Loss
 
|Loss
|MAG13(kinase), BCL2 like and others
+
|''[[MAGI3]]'', BCL2 like and others
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 120: Line 120:  
|4q35.1
 
|4q35.1
 
|Loss
 
|Loss
|''[[DCTD]], [[ING2]],'' and others
+
|''[[DCTD]], [[ING2]]'' and others
 
|Recurrent
 
|Recurrent
 
|2
 
|2
Line 149: Line 149:  
|5p14.3
 
|5p14.3
 
|Gain
 
|Gain
|''CDH12,10''
+
|''[[CDH10]], [[CDH12]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 163: Line 163:  
|5q13.2
 
|5q13.2
 
|Loss
 
|Loss
|''[[OCLN]], [[NAIP]]'', and others
+
|''[[OCLN]], [[NAIP]]'' and others
 
|Recurrent
 
|Recurrent
 
|2
 
|2
 
|<ref name=":3" />
 
|<ref name=":3" />
 
|-
 
|-
| rowspan="7" |6
+
| rowspan="6" |6
 
|6p
 
|6p
 
|Gain
 
|Gain
Line 210: Line 210:  
|3
 
|3
 
|<ref name=":5" />
 
|<ref name=":5" />
|-
  −
|6q16.3
  −
|Loss
  −
|''[[COQR]], [[GRIK2]]''
  −
|Recurrent
  −
|3
  −
|<ref name=":1" />
   
|-
 
|-
 
| rowspan="4" |7
 
| rowspan="4" |7
Line 235: Line 228:  
|7p15.2
 
|7p15.2
 
|Gain
 
|Gain
|''[[CBX3]], etc''
+
|''[[CBX3]]'', etc
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 267: Line 260:  
|Recurrent
 
|Recurrent
 
|3
 
|3
|<ref name=":5" />  
+
|<ref name=":5" />
 
|-
 
|-
 
|8q
 
|8q
Line 285: Line 278:  
|8q24.3
 
|8q24.3
 
|Gain
 
|Gain
|''[[MAPK15]], [[TOP1MT]], [[CYP11B11]] (P450), ZNF41, 616, 707'' and ''ZNF517''
+
|''[[MAPK15]], [[TOP1MT]], [[CYP11B11]] (P450), [[ZNF41]], [[ZNF517]], [[ZNF616]]'' and ''[[ZNF707]]''  
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 365: Line 358:  
|11q13.1/q13.4
 
|11q13.1/q13.4
 
|Gain
 
|Gain
|''[[SCYL1]], [[MAP3K11]], [[CCND1]], [[FGF4]], [[FGF3]], [[NUMA]],'' and ''[[RELT]]''
+
|''[[SCYL1]], [[MAP3K11]], [[CCND1]], [[FGF4]], [[FGF3]], [[NUMA]]'' and ''[[RELT]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 576: Line 569:  
|19p/ 19p13
 
|19p/ 19p13
 
|Gain
 
|Gain
|''ICAM4,ICAM4, [[IBCL2L12]], [[TYK2]], [[IL2]],'' and ''[[DNMT1]]''
+
|''ICAM4, ICAM4, [[IBCL2L12]], [[TYK2]], [[IL2]]'' and ''[[DNMT1]]''
 
|Recurrent
 
|Recurrent
 
|3
 
|3
Line 635: Line 628:  
| rowspan="8" |X
 
| rowspan="8" |X
 
|X
 
|X
|Gain/ Loss
+
|Gain / Loss
 
|
 
|
 
|Recurrent
 
|Recurrent
Line 700: Line 693:  
|Genome wide load of CNA > 100Mb
 
|Genome wide load of CNA > 100Mb
 
|
 
|
|gain/loss
+
|Gain / Loss
 
|
 
|
 
|associated with significant change in GEP at relapse
 
|associated with significant change in GEP at relapse